Frequency of the frame-shifting CYP2D7 138delT polymorphism in a large, ethnically diverse sample population

Drug Metabolism and Disposition

Volumn 35, Issue 8, 2007, Pages 1251-1253

  Bhathena, Anahita ^a   Mueller, Toby ^a   Grimm, David R ^a   Idler, Ken ^a   Tsurutani, Alan ^a   Spear, Brian B ^a   Katz, David A ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 2D7; UNCLASSIFIED DRUG;

AFRICAN AMERICAN; ALLELE; ARTICLE; ASIAN; CAUCASIAN; DNA POLYMORPHISM; DRUG RESPONSE; ETHNIC GROUP; ETHNICITY; GENE DELETION; GENE FREQUENCY; GENE SEQUENCE; GENETIC TRANSCRIPTION; GENOTYPE; HISPANIC; HUMAN; INDIAN; NUCLEOTIDE SEQUENCE; POPULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOP CODON;

AFRICAN AMERICANS; ALTERNATIVE SPLICING; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN; CODON, NONSENSE; CYTOCHROME P-450 ENZYME SYSTEM; EUROPEAN CONTINENTAL ANCESTRY GROUP; FRAMESHIFT MUTATION; GENE DELETION; GENE FREQUENCY; GENOTYPE; HISPANIC AMERICANS; HUMANS; POLYMORPHISM, GENETIC;

EID: 34547154407     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.107.014993     Document Type: Article

References (9)

1. Bernard S, Neville KA, Nguyen AT, and Flockhart DA (2006) Interethnic differences in genetic polymorphisms of CYP2D6 in the U.S. population: clinical implications. Oncologist 11:126-135.
2. Furman KD, Grimm DR, Mueller T, Holley-Shanks RR, Bertz RJ, Williams LA, Spear BB, and Katz DA (2004) Impact of CYP2D6 intermediate metabolizer alleles on single-dose desipramine pharmacokinetics. Pharmacogenetics 14:279-284.
3. Gaedigk A, Gaedigk R, and Leeder JS (2005) CYP2D7 splice variants in human liver and brain: does CYP2D7 encode functional protein? Biochem Biophys Res Commun 336:1241-1250.
4. Gaedigk A and Leeder JS (2006) Comments on Hoskins et al. [(2005) Drug Metab Dispos 33:1564-1565]. Drug Metab Dispos 34:504-505; author reply 34:506.
5. Hoskins JM, Marsh S, and McLeod HL (2005) Comment on "A frameshift mutation and alternate splicing in human brain generate a functional form of the pseudogene cytochrome P4502d7 that demethylates codeine to morphine." Drug Metab Dispos 33:1564-1565; author reply 33:1566.
6. Kimura S, Umeno M, Skoda RC, Meyer UA, and Gonzalez FJ (1989) The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene. Am J Hum Genet 45:889-904.
7. Løvlie R, Daly AK, Matre GE, Molven A, and Steen VM (2001) Polymorphisms in CYP2D6 duplication-negative individuals with the ultrarapid metabolizer phenotype: a role for the CYP2D6*35 allele in ultrarapid metabolism? Pharmacogenetics 11:45-55.
8. Pai HV, Kommaddi RP, Chinta SJ, Mori T, Boyd MR, and Ravindranath V (2004) A frameshift mutation and alternate splicing in human brain generate a functional form of the pseudogene cytochrome P4502D7 that demethylates codeine to morphine. J Biol Chem 279:27383-27389.
9. Zanger UM, Raimundo S, and Eichelbaum M (2004) Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry. Naunyn Schmiedebergs Arch Pharmacol 369:23-37.